These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 18561175

  • 1. Valacyclovir and acyclovir pharmacokinetics in immunocompromised children.
    Bomgaars L, Thompson P, Berg S, Serabe B, Aleksic A, Blaney S.
    Pediatr Blood Cancer; 2008 Oct; 51(4):504-8. PubMed ID: 18561175
    [Abstract] [Full Text] [Related]

  • 2. An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children.
    Nadal D, Leverger G, Sokal EM, Floret D, Perel Y, Leibundgut K, Weller S.
    J Infect Dis; 2002 Oct 15; 186 Suppl 1():S123-30. PubMed ID: 12353197
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: can intravenous acyclovir be substituted by oral valacyclovir?
    Eksborg S, Pal N, Kalin M, Palm C, Söderhäll S.
    Med Pediatr Oncol; 2002 Apr 15; 38(4):240-6. PubMed ID: 11920787
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Valacyclovir in the treatment of genital herpes and herpes zoster.
    Baker DA.
    Expert Opin Pharmacother; 2002 Jan 15; 3(1):51-8. PubMed ID: 11772333
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
    Tyring SK, Douglas JM, Corey L, Spruance SL, Esmann J.
    Arch Dermatol; 1998 Feb 15; 134(2):185-91. PubMed ID: 9487210
    [Abstract] [Full Text] [Related]

  • 11. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.
    Arora A, Mendoza N, Brantley J, Yates B, Dix L, Tyring S.
    J Infect Dis; 2008 May 01; 197(9):1289-95. PubMed ID: 18422441
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Valacyclovir HCl (Valtrex): an acyclovir prodrug with improved pharmacokinetics and better efficacy for treatment of zoster.
    Smiley ML, Murray A, de Miranda P.
    Adv Exp Med Biol; 1996 May 01; 394():33-9. PubMed ID: 8815698
    [No Abstract] [Full Text] [Related]

  • 18. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults.
    Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ.
    Antimicrob Agents Chemother; 1995 Jul 01; 39(7):1546-53. PubMed ID: 7492102
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lack of a pharmacokinetic interaction between steady-state tipranavir/ritonavir and single-dose valacyclovir in healthy volunteers.
    Sabo JP, Cong XJ, Kraft MF, Wallace L, Castles MA, Mauss S, MacGregor TR.
    Eur J Clin Pharmacol; 2011 Mar 01; 67(3):277-81. PubMed ID: 20963404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.